16-1614811-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_020825.4(CRAMP1):c.172G>A(p.Gly58Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000011 in 1,278,034 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020825.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CRAMP1 | NM_020825.4 | c.172G>A | p.Gly58Ser | missense_variant | 2/21 | ENST00000397412.8 | NP_065876.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CRAMP1 | ENST00000397412.8 | c.172G>A | p.Gly58Ser | missense_variant | 2/21 | 5 | NM_020825.4 | ENSP00000380559.2 | ||
CRAMP1 | ENST00000293925.9 | c.172G>A | p.Gly58Ser | missense_variant | 1/20 | 5 | ENSP00000293925.5 | |||
CRAMP1 | ENST00000674071.1 | c.*13G>A | downstream_gene_variant | ENSP00000501151.1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151598Hom.: 0 Cov.: 31
GnomAD4 exome AF: 0.0000107 AC: 12AN: 1126436Hom.: 0 Cov.: 29 AF XY: 0.0000147 AC XY: 8AN XY: 543268
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151598Hom.: 0 Cov.: 31 AF XY: 0.0000270 AC XY: 2AN XY: 74028
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 28, 2024 | The c.172G>A (p.G58S) alteration is located in exon 1 (coding exon 1) of the CRAMP1 gene. This alteration results from a G to A substitution at nucleotide position 172, causing the glycine (G) at amino acid position 58 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at